Holocene Advisors
IRWD icon

Holocene Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Holocene Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-28,373
Closed -$293K – 721
2020
Q2 		$293K Buy
+28,373
New +$290K ﹤0.01% 566
2018
Q2 		– Sell
-19,204
Closed -$248K – 641
2018
Q1 		$248K Sell
19,204
-22,853
-54% -$285K 0.01% 454
2017
Q4 		$528K Buy
+42,057
New +$549K 0.01% 395

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Holocene Advisors's IRWD Position: Q3 2020 in Review

Holocene Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 28,373 shares — an estimated $293K sold.

Holocene Advisors first reported a position in IRWD in Q4 2017 and held it in 3 quarters. The position peaked at $528K in Q4 2017. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

  • Holocene Advisors reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Holocene Advisors sold 28,373 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $293K.
  • Holocene Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Holocene Advisors's Ironwood Pharmaceuticals position peaked at $528K in Q4 2017.
  • 190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on Holocene Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.